Ciência Nordeste

Mapa Instituições Programas Sobre

Rede de colaboração Produção

Carregando rede…

PD

Paula Lana de Miranda Drummond

Fundação Ezequiel Dias · PE · 18 publicações em 2022–2026

ORCID 0000-0002-4639-7424

Multiple Myeloma Research and TreatmentsPharmacovigilance and Adverse Drug ReactionsBone health and treatmentsPharmaceutical Practices and Patient OutcomesCancer survivorship and care

Principais coautores no Nordeste tamanho = publicações em comum

Roberta Márcia Marques dos Santos Cristine de Araújo Silva Bruno Pereira

Publicações recentes

2026 4

Clinical Benefit of Multiple Myeloma Drugs at Regulatory Approval in Brazil, Europe, and the USA: A Retrospective Cohort Study (2003–2024)
Medicina · Clinical Drug Investigation
Identifying the Initiation of a New Line of Therapy for Metastatic Lung, Breast, and Colorectal Cancer in Real‐World Data: A Scoping Review
Profissões da saúde · Pharmacoepidemiology and Drug Safety
HIV resistance to integrase strand-transfer inhibitors: disproportionality analysis of individual case safety reports from the WHO global safety database (VigiBase)
Medicina · Current Medical Research and Opinion
Therapeutic Horizon in Multiple Myeloma: Analysis of the Emerging Landscape of Clinical Trials
Medicina · Therapeutic Innovation & Regulatory Science

2025 3

Peripheral Neuropathy Associated With Proteasome Inhibitors and Immunomodulatory Drugs: A Pharmacovigilance Disproportionality Analysis Using VigiBase
Farmacologia e toxicologia · Pharmacology Research & Perspectives
Efficacy and safety of thalidomide for oncology-related uses approved in Brazil: An overview of systematic reviews
Medicina · Journal of Oncology Pharmacy Practice
Off-label use of thalidomide in children with Crohn's disease and inflammatory bowel diseases
Medicina · Einstein (São Paulo)

2024 2

Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009–2020
Medicina · Annals of Hematology
Multiple Myeloma Drug Therapy: Considerations on Effectiveness and Safety
Medicina · Interdisciplinary cancer research

2023 6

Chemotherapy-Induced Peripheral Neuropathy Impacts Quality of Life and Activities of Daily Living of Brazilian Multiple Myeloma Patients
Medicina · Current Drug Safety
Comparison of three risk assessment models for thromboembolism in multiple myeloma patients receiving immunomodulators: a Brazilian historical cohort
Medicina · Journal of Thrombosis and Thrombolysis
Real-world effectiveness and safety of multiple myeloma treatments based on thalidomide and bortezomib: A retrospective cohort study from 2009 to 2020 in a Brazilian metropolis
Medicina · Cancer Epidemiology
Health-related quality of life and use of medication with anticholinergic activity in patients with multiple myeloma
Medicina · Supportive Care in Cancer
Factors associated with potentially inappropriate medications in elderly with multiple myeloma
Medicina · Journal of Oncology Pharmacy Practice
Incidence of thromboembolism and associated factors in multiple myeloma patients treated with immunomodulatory drugs: a retrospective analysis in Belo Horizonte, Brazil
Medicina · Supportive Care in Cancer

2022 3

Use of fall risk-increasing drugs in older adults with multiple myeloma: A cross-sectional study
Medicina · Journal of Geriatric Oncology
Effect of therapeutic regimens and polypharmacy on health-related quality of life of people with multiple myeloma: a cross-sectional study in Belo Horizonte, Brazil
Medicina · Current Medical Research and Opinion
Health-related quality of life of multiple myeloma patients after the first-line treatment: results of a prospective cohort study
Medicina · Research Society and Development

Contagens só com publicações em revistas com Qualis (filtro na tela inicial). Dados obtidos de fontes abertas: OpenAlex (CC0), ROR (CC0), CAPES Dados Abertos (CC-BY), INEP e IBGE. Encontrou um erro sobre você? Saiba mais. Criado por Gabriel Pina.